Use este identificador para citar ou linkar para este item: http://hdl.handle.net/1843/41440
Tipo: Artigo de Periódico
Título: Evaluation of antitumor activity and cardiac toxicity of a bone-targeted ph-sensitive liposomal formulation in a bone metastasis tumor model in mice
Autor(es): Diego dos Santos Ferreira
Bruno Luís Jesus de Oliveira Pinto
Vidhya Kumar
Valbert Nascimento Cardoso
Simone Odília Fernandes
Cristina Maria Souza
Geovanni Dantas Cassali
Anna Moore
David Edwin Sosnovik
Christian Taylor Farrar
Elaine Amaral Leite
Ricardo José Alves
Mônica Cristina de Oliveira
Alexander Ramos Guimarães
Peter Caravan
Resumo: Chemotherapy for bone tumors is a major challenge because of the inability of therapeutics to penetrate dense bone mineral. We hypothesize that a nanostructured formulation with high affinity for bone could deliver drug to the tumor while minimizing off-target toxicity. Here, we evaluated the efficacy and toxicity of a novel bone-targeted, pH-sensitive liposomal formulation containing doxorubicin in an animal model of bone metastasis. Biodistribution studies with the liposome showed good uptake in tumor, but low accumulation of doxorubicin in the heart. Mice treated with the bone-targeted liposome formulation showed a 70% reduction in tumor volume, compared to 35% reduction for free doxorubicin at the same dose. Both cardiac toxicity and overall mortality were significantly lower for animals treated with the bone-targeted liposomes compared to free drug. Bone-targeted, pH-sensitive, doxorubicin containing liposomes represent a promising approach to selectively delivering doxorubicin to bone tumors while minimizing cardiac toxicity.
Assunto: Atividade antitumoral
Toxicidade cardíaca
Modelo de tumor
Metástase óssea
Camundongos
Idioma: eng
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Instituição: UFMG
Departamento: FAR - DEPARTAMENTO DE ALIMENTOS
FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS
FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS
ICB - DEPARTAMENTO DE PATOLOGIA
Tipo de Acesso: Acesso Aberto
Identificador DOI: 10.1016/j.nano.2017.03.005
URI: http://hdl.handle.net/1843/41440
Data do documento: Jul-2017
metadata.dc.url.externa: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483199/
metadata.dc.relation.ispartof: Nanomedicine: Nanotechnology, Biology and Medicine
Aparece nas coleções:Artigo de Periódico



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.